Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
We've hit a 2-year high, even though the company is closed.
The connection with PwC HK is a curiosity
I was visiting the office there and guess who I saw working there?
None other than the big S himself. He looked really well and fit, but a little tired around the eyes, yet ... very enthusiastic.
So I expect good things to happen with alif!
P.S. Like you, everything I say here is pure speculation and entertainment for the readers.
Maybe Mr. STRONG
Will provide us with more details. Although he is now employed elsewhere he is familiar on whats happening to the remnants of Alif and why the alif stock is still trading.
Alif and Cryptocurrency security
New ALIF investor may take Co. into the cryptocurrency security blockchain technology market. AI proprietary software can be applied to this usage very easily.
Wow What a turnaround
New Prospects?
Due to the current state of the Co., I believe the owners may be trying to sell their majority stake to Asian investors. This includes Alife Studios, which has also been closed. This could explain why the Co.'s shares have not been withdrawn from the market.
Silly, that doesn't make the truth go away!
This appears to affirm that Alife is bankrupt and out of business. Who's going to power down the Alife Web server?
Poor Zachs...
Insiders took advantage of the quarterly report to unload shares, knowing that prospects in the near-term don't look good.
Look for continued weakness during the next 6 months. Don't be surprised if the stock falls into the $20 range.
Zacks raises SLCA to Strong Buy
However the stock is under strong selling pressure, down to 45 from from its recent $60 range.
Without fracking,SLCA will continue to struggle.
Oh don’t worry
Another disease hysteria will trigger another Govx vaccine initiative! It’s a great business model – you don’t have to actually produce anything and yet a new crop of investors will buy into the fantasy.
Desperation
He's a big time seller of this POS. That's why he's spamming so much for others to buy in!
He needs to unload before GOVX crashes again to .04 or lower.
breakout coming? Maybe... but which way up or down?
GOVX has been in business 15 years and never succeeded at producing any vaccines. In 2002 the pps was $22. The stock has been diluted over a 100 fold since then.
Serious pumping began in early August of this year when the $7.8M award by DHS was announced. However, that contract is staged, with the first payment being only $200K. There is no guarantee that GOVX will reach all the milestones required by the contract and may therefore not receive the full amount of the contract.
Insiders have been unloading as fast as buyers come forth, which is why the stock hasn't zoomed up, as it would otherwise have done.
Don't be too greedy! Take your profit and run!
Second Quarter 2016 Highlights
Total Revenue increased by 34.2% year-on-year to $287.0 million. Revenue from e-commerce services increased by 77.4% year-on-year to $189.5 million.
Operating loss was $32.8 million. Non-GAAP operating loss was $30.3 million. A description of the adjustments from GAAP to non-GAAP operating loss is detailed in the Reconciliation Statement following this earnings release.
Net loss attributable to Fang's shareholders was $40.6 million. Fully diluted loss per ADS was $0.09.
Non-GAAP net loss attributable to Fang's shareholders was $39.5million. Non-GAAP fully diluted loss per ADS was $0.08. A description of the adjustments from GAAP to non-GAAP net loss attributable to Fang's shareholders and fully diluted loss per ADS is detailed in the Reconciliation Statement following this earnings release.
GMV increased by 68% from $6.8 billion in the second quarter of 2015 to $11.4 billion in the second quarter. The following table shows GMV by quarter for the periods indicated.
Zzzzzzzz
AI is now main stream and growing by leaps and bounds. It's been over a year since you have reported any status
on Alife & Studio and your web sites have been silent. I've been cruising around in Victoria Harbour waiting for
something to happen.
It's now evident you were really wrong!
Based on unfavorable Zacks Rank and negative earnings trend over the last four quarters, I prefer to avoid SouFun Holdings Ltd (SFUN). This stock carries a Zacks Rank #5 (Strong Sell) and has four quarters of average negative surprise. Also, this stock witnessed negative estimate revisions over the last few weeks.
Zika vaccines tested by Walter Reed,Beth Israel,Harvard Medical
http://www.bbc.com/news/health-36645822
Inovio first human trial of a Zika vaccine will begin soon
Inovio, which is based in Plymouth Meeting, Pennsylvania, and GeneOne Life Science, which is based in Seoul, South Korea, worked together on the vaccine. They previously collaborated to create vaccines for Ebola and MERS, both of which are being tested.
Pressure from insider trading
timed to coincide with PR News killed a potential run up orchestrated by pumpers.
Not waiting for an encore?
In perspective:
The grant is for $740,456 the first year; most of which fund the CEO&VPs salaries. The remaining $658,159 is for the second year.
Common Stock:.......... 75M authorized, 32M outstanding
Preferred Stock:.......... 10M – convertible to common stock
Warrants and Options:.. 54M common stock (potential dilution)
-------------------------------------------------------------
Take away: 42M shares chasing yearly revenue of $740K
Note: GOVT has been in operation for 15 years.
I was traveling in Central America on business last month, when to my surprise I encountered a full page advertisement in a local magazine for robotic surgery using the Da Vinci Si system. The ad was placed by the National Hospital of Costa Rica and featured a very detailed photo of the Si system and listed the types of procedures the system is capable of performing. The ad also showed four smaller photos of surgeons using the apparatus.
It was a very impressive and informative ad. Costa Rica is a well known destination for patients seeking advanced treatment at an affordable cost. Patients from Canada, US and Europe go to Costa Rica for operations and post op recovery in a tropical setting.
For a good pump & dump operation
Check out GOVX
Look at this SEC filing for selling 10M shares
SEC filing: 1/1/2016 : PROSPECTUS GEOVAX LABS
GOVX close to the Zika virus vaccine
Govx has never developed a successful virus vaccine. I don't think it ever will. That's why the PPS has been steadily declining since 2011.
1 seller who walked us down a bit,
And I have more to dump!
For those of us who have tens of thousands of shares
This is a very Good time to SELL!
Bye, Pump & Dumper
Plan for Zika virus vaccine?
Patient STXS has been steadily dying
since June 2011. It reached a new all-time Low on 1/19/16.
Looked into it and concluded
I believe your due diligence conclusion is flawed. You are about to be impaled by a falling knife. I agree with Zacks Strong Sell signal dated 1/6/16 for the following reasons:
1. The purchase of bankrupt Response Genetics, Inc. for $14M was a mistake. It will be very difficult to generate positive cash flow from those assets.
2. CGIX is predominately a laboratory testing services company, both clinical and biopharma. However, that core business continues to operate at a loss.
3. In 2014 the company, in an attempt to turn around its losses, created a new business unit dedicated to research and development of new proprietary genomic tests. I believe that was a strategic mistake and will become a major liability. That sort of research is better left to universities and startup companies focused solely on research.
4. To makeup for revenue shortcoming, the common stock has been diluted. My target price for 2016 is 50 cents.
Can someone explain why
This stock has crashed from $12(7/2015)to $2?
The problem is
the company has been stuck in phases 1 & 2 for 15 years!
It's a waste of money to wait decades for revenue.
If GeoVax is so good why is stock low?
1. The GeoVax ebola vaccine is irrelevant.
There are already multiple effective vaccines already in use.
2. Govt NIH funding has been steadily declining.
3. Because of #2 the company has issued more stock
diluting its real value to .02
4. It’s only a matter of time before the gravy bubble pops.
WHO: Trials show new Ebola vaccine is 'highly effective'
A newly developed vaccine against the deadly Ebola virus is "highly effective" and could help prevent its spread in the current and future outbreaks, the World Health Organization said Friday.
Trials of the single-dose VSV-EBOV vaccine began in March in Guinea -- one of three West African nations at the center of the recent outbreak -- and have shown such promise that this week it was decided to extend immediate vaccination to "all people at risk" after close contact with an infected person, a WHO statement said.
Sounds like an advertisement.
Is the company up for sale? If not, I think you should consider a paradigm shift; transfer your operation to India's Bengaluru high tech region and apply your skills to the pharma and medical industries. Costs in India are considerably lower than Hong Kong (or anywhere else) and there is an unlimited supply of computer professionals to draw from. There are all kinds of AI/AR applications for drug discovery and development simulation software. There is also the opportunity to invent patient apps that supplement drug intake regimens and to enhance drug efficacy.
Give it some thought.
Stock down -9.20% today
Bad news causing insiders to cash out?
Could be that further dilution will cause price to drop to .10
Gee, only 300K NIH Grant for 12 months
They will burn through that in 1 month!
UNC Chapel Hill and GSK form Qura Therapeutics for HIV products
www.wncn.com/story/29027089/carolina-partners-with-gsk-to-seek-cure-for-hiv